Trials / Completed
CompletedNCT06952127
Feasibility and Preliminary Efficacy of a Group-based Telerehabilitation Program in People With Post-COVID-19 Sequelae (TEPCO).
Pilot Study Evaluating the Feasibility and Appropriateness of a Telerehabilitation Exercise Program in People With Post-COVID-19 Sequelae: a Single-center Randomized Trial.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study pilot randomized controlled study is to evaluate the feasibility of the study procedures and to compare the preliminary efficacy of a rehabilitation program given in a "remote" (telerehabilitation) or "face-to-face" model for adult patients who had confirmed SARS-CoV-2 infection and still have symptoms after eight weeks of infection. The main question it aims to answer is: * Are the study procedures feasible? * Will the two groups have similar results for the preliminary efficacy outcomes? Researchers will compare group telerehabilitation to a face-to-face group to see if it's comparable. Participants will: * Take part in a 60-minute training session, 3 times a week in person or remotely * Visit the clinic before starting the training program and after 8 weeks of training * Keep a diary of their symptoms, if any
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Rehabilitation program | * 5-minute warm-up including easy global exercises * 5 resistance training exercises targeting upper and lower muscle groups * 30 secondes break between sets * Cooldown with breathing and stretching exercises |
Timeline
- Start date
- 2023-04-07
- Primary completion
- 2024-03-29
- Completion
- 2024-03-29
- First posted
- 2025-04-30
- Last updated
- 2025-04-30
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT06952127. Inclusion in this directory is not an endorsement.